Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug ...
Gogo boosted its year-over-year sales significantly in the fourth quarter of 2024 — a period in which Gogo acquired Satcom Direct — but posted a net loss.
The latest changes are 'probably the best thing to happen to people who’ve experienced it,' one businesswoman said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback